276 related articles for article (PubMed ID: 29751285)
1. Improving identification and management of familial hypercholesterolaemia in primary care: Pre- and post-intervention study.
Weng S; Kai J; Tranter J; Leonardi-Bee J; Qureshi N
Atherosclerosis; 2018 Jul; 274():54-60. PubMed ID: 29751285
[TBL] [Abstract][Full Text] [Related]
2. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
[TBL] [Abstract][Full Text] [Related]
3. Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation.
Watts GF; Gidding S; Wierzbicki AS; Toth PP; Alonso R; Brown WV; Bruckert E; Defesche J; Lin KK; Livingston M; Mata P; Parhofer KG; Raal FJ; Santos RD; Sijbrands EJ; Simpson WG; Sullivan DR; Susekov AV; Tomlinson B; Wiegman A; Yamashita S; Kastelein JJ;
Eur J Prev Cardiol; 2015 Jul; 22(7):849-54. PubMed ID: 24776375
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of improving identification of familial hypercholesterolaemia in general practice: intervention development study.
Qureshi N; Weng S; Tranter J; El-Kadiki A; Kai J
BMJ Open; 2016 May; 6(5):e011734. PubMed ID: 27231005
[TBL] [Abstract][Full Text] [Related]
5. Treatment pattern of familial hypercholesterolemia in Slovakia: Targets, treatment and obstacles in common practice.
Vohnout B; Fábryová Ľ; Klabník A; Kadurová M; Bálinth K; Kozárová M; Bugáňová I; Sirotiaková J; Rašlová K
Atherosclerosis; 2018 Oct; 277():323-326. PubMed ID: 30270066
[TBL] [Abstract][Full Text] [Related]
6. What have we learned from Turkish familial hypercholesterolemia registries (A-HIT1 and A-HIT2)?
Kayikcioglu M; Tokgozoglu L; Dogan V; Ceyhan C; Tuncez A; Kutlu M; Onrat E; Alici G; Akbulut M; Celik A; Yesilbursa D; Sahin T; Sonmez A; Ozdogan O; Temizhan A; Kilic S; Bayram F; Sabuncu T; Coskun FY; Ildizli M; Durakoglugil E; Kirilmaz B; Yilmaz MB; Yigit Z; Yildirim AB; Gedikli O; Topcu S; Oğuz A; Demir M; Yenerçağ M; Yıldırır A; Demircan S; Yilmaz M; Kaynar LG; Aktan M; Durmus RB; Gokce C; Ozcebe Oİ; Akyol TK; Okutan H; Sag S; Gul OO; Salcioglu Z; Altunkeser BB; Kuku I; Yasar HY; Kurtoglu E; Kose MD; Demircioglu S; Pekkolay Z; Ilhan O; Can LH
Atherosclerosis; 2018 Oct; 277():341-346. PubMed ID: 30270069
[TBL] [Abstract][Full Text] [Related]
7. Current management of children and young people with heterozygous familial hypercholesterolaemia - HEART UK statement of care.
Ramaswami U; Humphries SE; Priestley-Barnham L; Green P; Wald DS; Capps N; Anderson M; Dale P; Morris AA
Atherosclerosis; 2019 Nov; 290():1-8. PubMed ID: 31536851
[TBL] [Abstract][Full Text] [Related]
8. Statin treatment and LDL-cholesterol treatment goal attainment among individuals with familial hypercholesterolaemia in primary care.
Iyen B; Akyea RK; Weng S; Kai J; Qureshi N
Open Heart; 2021 Oct; 8(2):. PubMed ID: 34702779
[TBL] [Abstract][Full Text] [Related]
9. Establishing a national screening programme for familial hypercholesterolaemia in Lithuania.
Petrulioniene Z; Gargalskaite U; Kutkiene S; Staigyte J; Cerkauskiene R; Laucevicius A
Atherosclerosis; 2018 Oct; 277():407-412. PubMed ID: 30270078
[TBL] [Abstract][Full Text] [Related]
10. Improving identification of familial hypercholesterolaemia in primary care: derivation and validation of the familial hypercholesterolaemia case ascertainment tool (FAMCAT).
Weng SF; Kai J; Andrew Neil H; Humphries SE; Qureshi N
Atherosclerosis; 2015 Feb; 238(2):336-43. PubMed ID: 25555265
[TBL] [Abstract][Full Text] [Related]
11. Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers.
Akhabue E; Rittner SS; Carroll JE; Crawford PM; Dant L; Laws R; Leo MC; Puro J; Persell SD
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28673901
[TBL] [Abstract][Full Text] [Related]
12. How to implement clinical guidelines to optimise familial hypercholesterolaemia diagnosis and treatment.
Farnier M; Civeira F; Descamps O;
Atheroscler Suppl; 2017 Apr; 26():25-35. PubMed ID: 28434482
[TBL] [Abstract][Full Text] [Related]
13. Detection and management of familial hypercholesterolaemia in primary care in Australia: protocol for a pragmatic cluster intervention study with pre-post intervention comparisons.
Arnold-Reed DE; Brett T; Troeung L; Vickery A; Garton-Smith J; Bell D; Pang J; Grace T; Bulsara C; Li I; Bulsara M; Watts GF
BMJ Open; 2017 Oct; 7(10):e017539. PubMed ID: 29061621
[TBL] [Abstract][Full Text] [Related]
14. Are patients with familial hypercholesterolaemia well managed in lipid clinics? An audit of eleven clinics from the Department of Health Familial Hypercholesterolaemia Cascade Testing project.
Hadfield SG; Horara S; Starr BJ; Yazdgerdi S; Bhatnagar D; Cramb R; Egan S; Everdell R; Ferns G; Jones A; Marenah CB; Marples J; Prinsloo P; Sneyd A; Stewart MF; Sandle L; Wang T; Watson MS; Humphries SE
Ann Clin Biochem; 2008 Mar; 45(Pt 2):199-205. PubMed ID: 18325186
[TBL] [Abstract][Full Text] [Related]
15. Coronary heart disease mortality in treated familial hypercholesterolaemia: Update of the UK Simon Broome FH register.
Humphries SE; Cooper JA; Seed M; Capps N; Durrington PN; Jones B; McDowell IFW; Soran H; Neil HAW;
Atherosclerosis; 2018 Jul; 274():41-46. PubMed ID: 29751283
[TBL] [Abstract][Full Text] [Related]
16. Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).
; Vallejo-Vaz AJ; De Marco M; Stevens CAT; Akram A; Freiberger T; Hovingh GK; Kastelein JJP; Mata P; Raal FJ; Santos RD; Soran H; Watts GF; Abifadel M; Aguilar-Salinas CA; Al-Khnifsawi M; AlKindi FA; Alnouri F; Alonso R; Al-Rasadi K; Al-Sarraf A; Ashavaid TF; Binder CJ; Bogsrud MP; Bourbon M; Bruckert E; Chlebus K; Corral P; Descamps O; Durst R; Ezhov M; Fras Z; Genest J; Groselj U; Harada-Shiba M; Kayikcioglu M; Lalic K; Lam CSP; Latkovskis G; Laufs U; Liberopoulos E; Lin J; Maher V; Majano N; Marais AD; März W; Mirrakhimov E; Miserez AR; Mitchenko O; Nawawi HM; Nordestgaard BG; Paragh G; Petrulioniene Z; Pojskic B; Postadzhiyan A; Reda A; Reiner Ž; Sadoh WE; Sahebkar A; Shehab A; Shek AB; Stoll M; Su TC; Subramaniam T; Susekov AV; Symeonides P; Tilney M; Tomlinson B; Truong TH; Tselepis AD; Tybjærg-Hansen A; Vázquez-Cárdenas A; Viigimaa M; Vohnout B; Widén E; Yamashita S; Banach M; Gaita D; Jiang L; Nilsson L; Santos LE; Schunkert H; Tokgözoğlu L; Car J; Catapano AL; Ray KK;
Atherosclerosis; 2018 Oct; 277():234-255. PubMed ID: 30270054
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes.
Nanchen D; Gencer B; Auer R; Räber L; Stefanini GG; Klingenberg R; Schmied CM; Cornuz J; Muller O; Vogt P; Jüni P; Matter CM; Windecker S; Lüscher TF; Mach F; Rodondi N
Eur Heart J; 2015 Sep; 36(36):2438-45. PubMed ID: 26142466
[TBL] [Abstract][Full Text] [Related]
18. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society.
Nordestgaard BG; Chapman MJ; Humphries SE; Ginsberg HN; Masana L; Descamps OS; Wiklund O; Hegele RA; Raal FJ; Defesche JC; Wiegman A; Santos RD; Watts GF; Parhofer KG; Hovingh GK; Kovanen PT; Boileau C; Averna M; Borén J; Bruckert E; Catapano AL; Kuivenhoven JA; Pajukanta P; Ray K; Stalenhoef AF; Stroes E; Taskinen MR; Tybjærg-Hansen A;
Eur Heart J; 2013 Dec; 34(45):3478-90a. PubMed ID: 23956253
[TBL] [Abstract][Full Text] [Related]
19. Familial hypercholesterolemia treatments: Guidelines and new therapies.
Raal FJ; Hovingh GK; Catapano AL
Atherosclerosis; 2018 Oct; 277():483-492. PubMed ID: 30270089
[TBL] [Abstract][Full Text] [Related]
20. LDL-cholesterol target achievement in patients with heterozygous familial hypercholesterolemia at Groote Schuur Hospital: Minority at target despite large reductions in LDL-C.
van Delden XM; Huijgen R; Wolmarans KH; Brice BC; Barron JK; Blom DJ; Marais AD
Atherosclerosis; 2018 Oct; 277():327-333. PubMed ID: 30270067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
